Correlation Between Candel Therapeutics and Aldeyra
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Aldeyra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Aldeyra into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Aldeyra, you can compare the effects of market volatilities on Candel Therapeutics and Aldeyra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Aldeyra. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Aldeyra.
Diversification Opportunities for Candel Therapeutics and Aldeyra
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Candel and Aldeyra is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Aldeyra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aldeyra and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Aldeyra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aldeyra has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Aldeyra go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Aldeyra
Given the investment horizon of 90 days Candel Therapeutics is expected to under-perform the Aldeyra. In addition to that, Candel Therapeutics is 1.22 times more volatile than Aldeyra. It trades about -0.05 of its total potential returns per unit of risk. Aldeyra is currently generating about -0.06 per unit of volatility. If you would invest 533.00 in Aldeyra on August 26, 2024 and sell it today you would lose (48.00) from holding Aldeyra or give up 9.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Candel Therapeutics vs. Aldeyra
Performance |
| Timeline |
| Candel Therapeutics |
| Aldeyra |
Candel Therapeutics and Aldeyra Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and Aldeyra
The main advantage of trading using opposite Candel Therapeutics and Aldeyra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Aldeyra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aldeyra will offset losses from the drop in Aldeyra's long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| Aldeyra vs. Tarsus Pharmaceuticals | Aldeyra vs. Travere Therapeutics | Aldeyra vs. Eton Pharmaceuticals | Aldeyra vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |